COMMUNIQUÉS West-GlobeNewswire

Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference
03/06/2026
NOVATO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra [...]
Monthly information on share capital and company voting rights
03/06/2026
PARIS, June 03, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the capital Total number of voting rights 05/31/2026 100,691,658 106,134,467 For further [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
03/06/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 03 juin 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
DBV Technologies Announces the Results of its 2026 Combined General Meeting
03/06/2026
Châtillon, France, June 3, 2026 DBV Technologies Announces the Results of its 2026 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq [...]
DBV Technologies annonce les résultats de son Assemblée Générale Mixte du 3 juin 2026
03/06/2026
Châtillon, France, le 3 juin 2026 DBV Technologies annonce les résultats de son Assemblée Générale Mixte du 3 juin 2026 Toutes les résolutions proposées à l’Assemblée Générale ont été adoptées DBV Technologies (Euronext [...]
Main Results of 2026 Annual and Extraordinary General Meeting
03/06/2026
The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg. All of the draft resolutions on the 2026 AGM [...]
Main Results of 2026 Annual and Extraordinary General Meeting
03/06/2026
REYKJAVÍK, Iceland and LUXEMBOURG, June 03, 2026 (GLOBE NEWSWIRE) -- The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House, 41A Avenue John F. Kennedy, [...]
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
03/06/2026
LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex [...]
Celularity Releases CEO Letter to Shareholders
03/06/2026
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular [...]
Range Impact Announces $10 Million Investment from Tacora Capital
03/06/2026
CLEVELAND, OHIO, June 03, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine properties [...]
Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
03/06/2026
First T cell therapy for a solid tumor cancer and first treatment option approved in Australia for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Iovance [...]
Jade Biosciences Announces Proposed Underwritten Public Offering
03/06/2026
SAN FRANCISCO and VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in- [...]
Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
03/06/2026
The company rises 196 spots to No. 791 on the Fortune 1000 2026 list following continued growth and momentum ORANGE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been named to [...]
Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting
03/06/2026
NANTES, France, June 3, 2026 – 8:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the "Company") , announced that it will hold its Annual General Meeting on June 24, 2026, at 10:00 am CET at Jones [...]
Assemblée Générale Mixte du 24 juin 2026 Modalités de mise à disposition des documents préparatoires à l’Assemblée
03/06/2026
NANTES, France, le 3 juin 2026, 20h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) (la « Société ») , annonce la tenue de son Assemblée Générale Mixte le 24 juin 2026 à 10h00 dans les locaux du [...]
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document
03/06/2026
2025 Audited financial statements are consistent with Unaudited financial statements previously reported on April 30, 2026 The IRIS Financing announced on May 28, 2026, was added as a subsequent event Confirmed cash [...]
OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025
03/06/2026
OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025 Les résultats financiers consolidés audités 2025 sont en [...]
Disclosure of transparency notification from FMR LLC
03/06/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 3 June 2026 – 6 PM CET Disclosure of transparency notification from FMR LLC Pursuant to the Belgian Act of 2 May 2007 on the disclosure of major [...]
VALNEVA:Declaration of shares and voting rights - Status as of May 31, 2026
03/06/2026
VALNEVA Declaration of shares and voting rights Status as of May 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint- [...]

Pages